JAAD 07/23 Dermatology Workforce in the United States – Part 2: Patient Outcomes, Challenges, and Potential Solutions

JAAD 06/23 Immunotherapy for Keratinocyte Cancers. Part 1: Immune-Related Epidemiology, Risk Factors, Pathogenesis, and Immunotherapy Management of Keratinocytic Cancers

JAAD 08/23 Part I: Cutaneous Manifestations of Cardiovascular Disease

JAAD 06/23 Immunotherapy for Keratinocyte Cancers. Part 2: Identification and Management of Cutaneous Side Effects of Immunotherapy Treatments

JAAD 08/23 Part II Cutaneous Manifestations of Peripheral Vascular Disease

JAAD 01/23 Dysplastic Nevus Part I: Historical Perspective, Classification, and Epidemiology

JAAD 01/23 Dysplastic Nevus Part II: Dysplastic Nevi: Molecular/Genetic Profiles and Management

JAAD 02/23 Disorders of Hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders

JAAD 03/23 Risk of melanoma and nonmelanoma skin cancer with immunosuppressants. Part I: Calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids

JAAD 02/23 Disorders of Hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation